BEHRENBRUCH CHRISTIAN (MD & Group CEO) purchased 0.3% of their position (67.94K shares) of TELIX PHARMACEUTICALS LTD on the open market
Open‑market purchase worth $996.7K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/7/2026ACC: 0001628280-26-031608
DirectorOfficer· MD & Group CEO
Since Mar 2026
+67.94K
Net shares
Net buyer
$996.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
67.94K acquired
Non-Derivative Transactions2
Ordinary Shares
Indirect
Shares
+34.50K
Price / share
$14.48
Trade value
$499.56K
% of position
0.2%
4/28/2026
20.68M→20.71M
Ordinary Shares
Indirect
Shares
+33.44K
Price / share
$14.87
Trade value
$497.18K
% of position
0.2%
4/29/2026
20.71M→20.74M
Total
Net shares
+67.94K
Net value
$996.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 4/28/2026 | P · Purchase | +34.50K | $14.48 | $499.56K | 0.2% | 20.68M | 20.71M |
| Ordinary Shares Indirect | 4/29/2026 | P · Purchase | +33.44K | $14.87 | $497.18K | 0.2% | 20.71M | 20.74M |
| Total | +67.94K | $996.74K | ||||||
Derivative Transactions0
No derivative transactions reported